Tocilizumab Antibody
Tocilizumab is a humanized monoclonal antibody that neutralizes the interleukin-6 receptor (IL-6R), inhibiting both classical and trans IL-6 signaling pathways. It is a critical research tool for studying inflammatory diseases like rheumatoid arthritis and has been investigated in clinical research for severe COVID-19 cytokine storm.
Product Specifications
Product Name Alternative
Tocilizumab, respiratory failure, rheumatoid, Inhibitor, Interleukin Related, Interleukin, IL-6R, inhibit, Neutralizing, arthritis, Anti-Human IL6R, Humanized Antibody, antibody, dyspnoea, COVID-19, coronavirus disease
Target
Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
21.5 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
145.2 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV649806 1.0 µg DNA
RDH12 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details ELI-39047h 96 Tests
Human Kinesin-like protein KIF18A, KIF18A ELISA KIT
Sign In for Pricing
View Details